Skip to main content

Table 1 Patient characteristics. CL: Common law marriage, SNF: Skilled Nursing Facility, DP: Domestic Partner. Other: Please refer to Appendix

From: Effect of metastatic site on survival in patients with neuroendocrine neoplasms (NENs). An analysis of SEER data from 2010 to 2014

Parameter

N

Percent

Age group

  < 60

781

38.95

60–70

684

34.11

  > 70

540

26.93

Sex

Male

1038

51.77

Female

967

48.23

Race

White

1636

81.6

Black

264

13.17

Other

96

4.79

Unknown

9

0.45

Marital status

Married / CL

1163

58

Unmarried or DP

5

0.25

Widowed

198

9.88

Divorced

226

11.27

Single

307

15.31

Unknown

106

5.29

Insurance

Insured

1398

69.73

Medicaid

228

11.37

Nonspecific

294

14.66

Uninsured

57

2.84

Unknown

28

1.4

Location of diagnosis

Hospital inpatient/ outpatient/ surgery

1976

98.55

Private physician

22

1.1

Laboratory

6

0.3

SNF/hospice

1

0.05

Primary site

Lung

437

21.8

Other

569

28.38

Pancreas

453

22.59

Small Bowel

546

27.23

Tumor size

  < =35

832

52.89

  > 35

741

47.11

Frequency Missing = 432

 Histology

Typical

496

24.74

Atypical/ high grade

1487

74.16

Pancreatic

22

1.1

Grade

Well differentiated or Grade 1

850

42.39

Moderately differentiated or Grade 2

382

19.05

Poorly differentiated or Grade 3

564

28.13

Undifferentiated / anaplastic

209

10.42

T status

N/A

422

21.05

T1 (all versions)

119

5.94

T2 (all versions)

340

16.96

T3 (all versions)

649

32.37

T4 (all versions)

468

23.34

T0

7

0.35

N status

Node negative or microscopic

598

29.83

Node positive

1148

57.26

N/A

259

12.92

M status

Metastatic

1891

94.31

N/A

114

5.69

Tumor size

  < =35

832

52.89

  > 35

741

47.11

Frequency Missing = 483

Liver metastasis

Yes

1553

77.46

No

437

21.8

N/A

15

0.75

Lung metastasis

Yes

186

9.28

No

1750

87.28

N/A

69

3.44

Bone metastasis

Yes

142

7.08

No

1808

90.17

N/A

55

2.74

Brain metastasis

Yes

124

6.18

No

1826

91.07

N/A

55

2.74

Surgery

Performed

954

47.58

Not advised

1013

50.52

Advised, not performed

27

1.35

N/A

11

0.55